Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.